BNP Paribas Financial Markets’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

BNP Paribas Financial Markets’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-38,243	Closed	-$1.65M	–	3686
2015 Q3	$1.65M	Sell	38,243 -71	-0.2%	-$3K	﹤0.01%	901
2015 Q2	$1.62M	Buy	+38,314	New	+$1.62M	﹤0.01%	953
2013 Q4	–	Sell	-22,540	Closed	-$618K	–	4173
2013 Q3	$618K	Buy	22,540 +231	+1%	+$5.47K	﹤0.01%	1401
2013 Q2	$468K	Buy	+22,309	New	+$436K	﹤0.01%	1609

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

BNP Paribas Financial Markets's WX Position: Q4 2015 in Review

BNP Paribas Financial Markets sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 38,243 shares — an estimated $1.65M sold.

BNP Paribas Financial Markets first reported a position in WX in Q2 2013 and held it in 4 quarters. The position peaked at $1.65M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

BNP Paribas Financial Markets reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
BNP Paribas Financial Markets sold 38,243 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $1.65M.
BNP Paribas Financial Markets first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 4 quarters.
BNP Paribas Financial Markets's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $1.65M in Q3 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2015, filed 10 Feb 2016.